^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    voxalatamab (JNJ-63898081)

    i
    Company:
    J&J
    Drug class:
    CD3 agonist, PSMA inhibitor
    Related drugs: